1. 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial. (15th December 2022) Authors: Denkinger, Claudia M; Janssen, Maike; Schäkel, Ulrike; Gall, Julia; Leo, Albrecht; Stelmach, Patrick; Weber, Stefan F; Krisam, Johannes; Baumann, Lukas; Stermann, Jacek; Merle, Uta; Weigand, Markus; Bullinger, Lars; Schrezenmeier, Jens-Florian; Bornhäuser, Martin; Alakel, Nael; Witzke, Oliver; Wo... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗